Article Information
History
- January 7, 2022.
Article Versions
- Version 1 (March 8, 2021 - 05:06).
- Version 2 (June 10, 2021 - 09:24).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lloyd A. C. Chapman1,2,*,
- Poojan Shukla1,
- Isabel Rodríguez-Barraquer1,3,
- Priya B. Shete4,5,
- Tomás M. León4,
- Kirsten Bibbins-Domingo3,6,
- George W. Rutherford6,7,
- Robert Schechter8 and
- Nathan C. Lo1,3,*
- 1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA
- 2Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
- 3Department of Medicine, University of California, San Francisco, San Francisco, CA
- 4Coronavirus Sciences Branch, California Department of Public Health, Richmond, CA, USA
- 5Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, CA, USA
- 6Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
- 7Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA
- 8Immunization Branch, California Department of Public Health, Richmond, CA, USA
- ↵*Correspondence:
Lloyd A. C. Chapman, PhD and Nathan C. Lo, MD PhD, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA 94110, lloyd.chapman1{at}lshtm.ac.uk, nathan.lo{at}ucsf.edu